Accessibility links Skip to main content

PhaRA

PhaRA specializes in a wide range of therapeutic areas, ranging from critical conditions to over-the-counter (OTC) products. The company’s experts have extensive experience with all types of products, including chemical and biological substances (such as monoclonal antibodies, vaccines, and ATMPs), antibody-drug conjugates (ADCs), medical devices, and combination products.

About us

PhaRA offers end-to-end regulatory services, ranging from global regulatory strategy and the preparation of regulatory, CMC, and medical documentation to global labeling management and the conduct of regulatory procedures within the European Union and at the World Health Organization (WHO). The company’s expertise covers the entire product lifecycle and supports clients from the early development phase through marketing authorization and ongoing lifecycle management.

A unique mix of junior and senior consultants forms the foundation of PhaRA’s collaborative and client-focused approach. The consulting firm strives to become an integral part of each client’s team and combines extensive regulatory expertise with practical, hands-on support. PhaRA was founded in 2002 by Ingrid Theeuwes and has built a strong reputation in the field of regulatory affairs. Ingrid is a pharmacist, holds a TOPRA diploma in EU regulation from Cardiff University in Wales, and has more than 20 years of experience in the field of international regulation.

Contact us


Contact

Fill out the form and we will contact you shortly.

Naam
Privacy Policy